Perrigo Company plc (PRGO) to Issue Quarterly Dividend of $0.29 on September 15th

Perrigo Company plc (NYSE:PRGO) declared a quarterly dividend on Thursday, July 30th. Shareholders of record on Friday, August 28th will be paid a dividend of 0.29 per share on Tuesday, September 15th. This represents a c) dividend on an annualized basis and a yield of 11.5%. The ex-dividend date is Friday, August 28th.

Perrigo has increased its dividend by an average of 0.1%annually over the last three years and has increased its dividend every year for the last 23 years. Perrigo has a payout ratio of 35.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Perrigo to earn $2.40 per share next year, which means the company should continue to be able to cover its $1.16 annual dividend with an expected future payout ratio of 48.3%.

Perrigo Trading Down 2.2%

PRGO stock opened at $10.09 on Friday. The company has a quick ratio of 1.59, a current ratio of 2.72 and a debt-to-equity ratio of 1.45. Perrigo has a twelve month low of $9.23 and a twelve month high of $27.33. The company has a market cap of $1.40 billion, a P/E ratio of -0.77, a PEG ratio of 1.22 and a beta of 0.51. The business has a fifty day moving average of $10.53 and a 200-day moving average of $11.64.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.04. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The firm had revenue of $841.80 million during the quarter, compared to analyst estimates of $1.04 billion. During the same period last year, the company earned $0.60 earnings per share. The company’s revenue was down 7.2% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities research analysts expect that Perrigo will post 2.11 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have issued reports on PRGO. Weiss Ratings raised shares of Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, July 21st. Zacks Research raised Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $19.33.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.